首页 | 本学科首页   官方微博 | 高级检索  
     

滋阴活血汤恩替卡韦治疗代偿期乙型肝炎肝硬化的临床效果
引用本文:张洪林,律正严,李海蓉. 滋阴活血汤恩替卡韦治疗代偿期乙型肝炎肝硬化的临床效果[J]. 国际医药卫生导报, 2017, 23(7). DOI: 10.3760/cma.j.issn.1007-1245.2017.07.046
作者姓名:张洪林  律正严  李海蓉
作者单位:1. 266300,胶州市人民医院中医科;2. 266300,胶州市心理康复医院内科
摘    要:目的 探讨滋阴活血汤、恩替卡韦治疗代偿期乙型肝炎肝硬化的临床效果.方法 收集2012年1月至2014年1月胶州市人民医院收治的代偿期乙型肝炎肝硬化患者98例,按照随机数字表法分为对照组与治疗组,各49例.对照组在对症支持治疗的基础上采用西药恩替卡韦治疗,治疗组在对症支持治疗的基础上采用滋阴活血汤联合恩替卡韦治疗.3个月为1个疗程,两组均治疗3个疗程后,追踪随访入选患者,比较两组肝纤维化指标、乙肝病毒标志物情况以及肝功能指标变化.结果 治疗组ALT复常率分别为73.5%、83.7%、89.8%和91.8%,均显著高于对照组,差异有统计学意义(均P<0.05);治疗组HBV DNA转阴率分别为73.5%、79.6%、85.7%和91.8%,均显著高于对照组,差异有统计学意义(均P< 0.05);治疗组总有效率(显效率+有效率)为95.9%,显著高于对照组的59.2%,差异有统计学意义(P<0.05);治疗组显效率显著高于对照组(73.5%比26.5%),差异有统计学意义(P<0.05);治疗组HA、Ⅲ型前胶原和Ⅳ型胶原指标均优于对照组,差异有统计学意义(均P< 0.05).结论 滋阴活血汤、恩替卡韦治疗代偿期乙型肝炎肝硬化可以明显改善患者临床症状,提高临床疗效,安全可靠,值得临床推广.

关 键 词:滋阴活血汤  恩替卡韦  代偿期乙型肝炎肝硬化

Ziyin Huoxue decoction and entecavir in treatment of decompensated hepatitis B cirrhosis
Zhang Honglin,Lyu Zhengyan,Li Hairong. Ziyin Huoxue decoction and entecavir in treatment of decompensated hepatitis B cirrhosis[J]. International Medicine & Health Guidance News, 2017, 23(7). DOI: 10.3760/cma.j.issn.1007-1245.2017.07.046
Authors:Zhang Honglin  Lyu Zhengyan  Li Hairong
Abstract:Objective To investigate the therapeutic effect of Ziyin Huoxue decoction and entecavir in the treatment of decompensated hepatitis B cirrhosis.Methods 98 cases of chronic hepatitis B cirrhosis treated at our hospital from January,2012 to January,2014 were randomly divided into a control group and a treatment group,49 cases for each group.The control group was given symptomatic support treatment and took entecavir;in addition,the treatment group was treated with Ziyin Huoxue decoction.3 months was 1 treatment course.Both groups were treated 3 courses.The patients were followed up.The liver fibrosis indicators,hepatitis B virus markers,and liver function indicators were compared between these two groups.Results The ALT recovery rates were 73.5%,83.7%,89.8%,and 91.8% in the treatment group,which were significantly higher than those in the control group,with statistical differences (all P < 0.05).The HBV DNA negative rates were 73.5%,79.6%,85.7%,and 91.8% in the treatment group,which were significantly higher than those in the control group,with statistical differences (all P < 0.05).The total efficacy was 95.9% in the treatment group and 59.2% in the control group,with a statistical difference (P < 0.05).The obviously effective rate was 73.5% in the treatment group and 26.5% in the control group,with a statistical difference (P < 0.05).The HA,procollagen type Ⅲ,and type Ⅳcollagen were better in the treatment group than in the control group,with statitical differences (all P < 0.05).Conclusions Ziyin Huoxue decoction and entecavir in the treatment of decompensated hepatitis B cirrhosis can significantly improve the patients' clinical symptoms and improve clinical curative effect and is safe and reliable,so it is worth being clinically generalized.
Keywords:Ziyin Huoxue decoction  Entecavir  Decompensated hepatitis B cirrhosis
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号